Matches in SemOpenAlex for { <https://semopenalex.org/work/W2982290167> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2982290167 endingPage "16" @default.
- W2982290167 startingPage "9" @default.
- W2982290167 abstract "ObjectiveTo assess the cost-effectiveness of first-line chemotherapy regimens for non-small cell lung cancer patients in Thailand.MethodsA Markov model comprising 3 health states (progression-free survival, progression, death) was used to estimate the long-term costs and health outcomes under a societal perspective with a lifetime horizon. Intervention was the combination of pemetrexed and cisplatin, AND the comparators were gemcitabine plus cisplatin and carboplatin plus paclitaxel. The efficacy and toxicity were obtained from landmark clinical trials, and the costs were based on a local Thai database. All costs and outcomes were discounted at 3%. The findings were reported as incremental cost-effectiveness ratios (ICERs) in both Thai baht (THB) and USD per quality-adjusted life year (QALY) gained. A series of sensitivity analyses, including 1-way and probabilistic sensitivity analyses, were performed. A cost-effectiveness acceptability curve was generated with a threshold of 160 000 THB/QALY or 4987 USD/QALY.ResultsUnder the base-case analysis, pemetrexed plus cisplatin had the greatest total cost among 3 regimens, yielding an ICER of 64 369.97 USD/QALY (2 064 989 THB/QALY) compared with gemcitabine plus cisplatin, and ICER of 8649.16 USD/QALY (277 465 THB/QALY) compared with carboplatin plus paclitaxel. The probabilistic sensitivity analysis results indicated that at the local Thai threshold, gemcitabine plus cisplatin was likely to be the most cost-effective regimen.ConclusionsAt the current price of pemetrexed, the combination of pemetrexed plus cisplatin was not found to be a cost-effective first-line regimen for patients with non-small cell lung cancer at the local Thai threshold compared with the gemcitabine plus cisplatin and carboplatin plus paclitaxel regimens." @default.
- W2982290167 created "2019-11-08" @default.
- W2982290167 creator A5008578055 @default.
- W2982290167 creator A5012746805 @default.
- W2982290167 creator A5039161221 @default.
- W2982290167 date "2020-05-01" @default.
- W2982290167 modified "2023-10-03" @default.
- W2982290167 title "Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand" @default.
- W2982290167 cites W1981352286 @default.
- W2982290167 cites W1984099760 @default.
- W2982290167 cites W1984886683 @default.
- W2982290167 cites W2029895102 @default.
- W2982290167 cites W2088095316 @default.
- W2982290167 cites W2099725888 @default.
- W2982290167 cites W2115658330 @default.
- W2982290167 cites W2131566228 @default.
- W2982290167 cites W2138234714 @default.
- W2982290167 cites W2145356422 @default.
- W2982290167 cites W2145835533 @default.
- W2982290167 cites W2166399931 @default.
- W2982290167 cites W2169875394 @default.
- W2982290167 cites W2318323252 @default.
- W2982290167 cites W2590136905 @default.
- W2982290167 cites W2729608918 @default.
- W2982290167 cites W2747125298 @default.
- W2982290167 cites W2747245783 @default.
- W2982290167 cites W2781525129 @default.
- W2982290167 doi "https://doi.org/10.1016/j.vhri.2019.04.005" @default.
- W2982290167 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31634796" @default.
- W2982290167 hasPublicationYear "2020" @default.
- W2982290167 type Work @default.
- W2982290167 sameAs 2982290167 @default.
- W2982290167 citedByCount "5" @default.
- W2982290167 countsByYear W29822901672019 @default.
- W2982290167 countsByYear W29822901672021 @default.
- W2982290167 countsByYear W29822901672022 @default.
- W2982290167 countsByYear W29822901672023 @default.
- W2982290167 crossrefType "journal-article" @default.
- W2982290167 hasAuthorship W2982290167A5008578055 @default.
- W2982290167 hasAuthorship W2982290167A5012746805 @default.
- W2982290167 hasAuthorship W2982290167A5039161221 @default.
- W2982290167 hasBestOaLocation W29822901671 @default.
- W2982290167 hasConcept C112930515 @default.
- W2982290167 hasConcept C126322002 @default.
- W2982290167 hasConcept C143998085 @default.
- W2982290167 hasConcept C2776256026 @default.
- W2982290167 hasConcept C2776694085 @default.
- W2982290167 hasConcept C2777240266 @default.
- W2982290167 hasConcept C2778239845 @default.
- W2982290167 hasConcept C2780258809 @default.
- W2982290167 hasConcept C2781413609 @default.
- W2982290167 hasConcept C2781451048 @default.
- W2982290167 hasConcept C3019080777 @default.
- W2982290167 hasConcept C515549039 @default.
- W2982290167 hasConcept C71924100 @default.
- W2982290167 hasConceptScore W2982290167C112930515 @default.
- W2982290167 hasConceptScore W2982290167C126322002 @default.
- W2982290167 hasConceptScore W2982290167C143998085 @default.
- W2982290167 hasConceptScore W2982290167C2776256026 @default.
- W2982290167 hasConceptScore W2982290167C2776694085 @default.
- W2982290167 hasConceptScore W2982290167C2777240266 @default.
- W2982290167 hasConceptScore W2982290167C2778239845 @default.
- W2982290167 hasConceptScore W2982290167C2780258809 @default.
- W2982290167 hasConceptScore W2982290167C2781413609 @default.
- W2982290167 hasConceptScore W2982290167C2781451048 @default.
- W2982290167 hasConceptScore W2982290167C3019080777 @default.
- W2982290167 hasConceptScore W2982290167C515549039 @default.
- W2982290167 hasConceptScore W2982290167C71924100 @default.
- W2982290167 hasFunder F4320321529 @default.
- W2982290167 hasLocation W29822901671 @default.
- W2982290167 hasOpenAccess W2982290167 @default.
- W2982290167 hasPrimaryLocation W29822901671 @default.
- W2982290167 hasRelatedWork W1967863863 @default.
- W2982290167 hasRelatedWork W2005371059 @default.
- W2982290167 hasRelatedWork W2022229528 @default.
- W2982290167 hasRelatedWork W2031554341 @default.
- W2982290167 hasRelatedWork W2349270370 @default.
- W2982290167 hasRelatedWork W2381460883 @default.
- W2982290167 hasRelatedWork W2471989939 @default.
- W2982290167 hasRelatedWork W3127521146 @default.
- W2982290167 hasRelatedWork W4233984594 @default.
- W2982290167 hasRelatedWork W2125019270 @default.
- W2982290167 hasVolume "21" @default.
- W2982290167 isParatext "false" @default.
- W2982290167 isRetracted "false" @default.
- W2982290167 magId "2982290167" @default.
- W2982290167 workType "article" @default.